Group One Trading’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-16,483
| Closed | -$81K | – | 9187 |
|
|
2021
Q3 | $81K | Buy |
+16,483
| New | +$80K | ﹤0.01% | 6121 |
|
|
2021
Q1 | – | Sell |
-1,044
| Closed | -$5.45K | – | 8233 |
|
|
2020
Q4 | $5K | Buy |
+1,044
| New | +$4.47K | ﹤0.01% | 6065 |
|
|
2020
Q3 | – | Sell |
-22,151
| Closed | -$85.7K | – | 6754 |
|
|
2020
Q2 | $57K | Sell |
22,151
-6,631
| -23% | -$19.5K | ﹤0.01% | 4273 |
|
|
2020
Q1 | $83K | Buy |
28,782
+3,963
| +16% | +$17.8K | ﹤0.01% | 3426 |
|
|
2019
Q4 | $94K | Buy |
24,819
+5,810
| +31% | +$27.8K | ﹤0.01% | 3680 |
|
|
2019
Q3 | $97K | Buy |
+19,009
| New | +$117K | ﹤0.01% | 3582 |
|
|
2019
Q2 | – | Sell |
-7,026
| Closed | -$40.4K | – | 5602 |
|
|
2019
Q1 | $50K | Sell |
7,026
-23,739
| -77% | -$213K | ﹤0.01% | 3575 |
|
|
2018
Q4 | $263K | Buy |
30,765
+10,500
| +52% | +$137K | ﹤0.01% | 2472 |
|
|
2018
Q3 | $406K | Buy |
20,265
+7,354
| +57% | +$173K | ﹤0.01% | 2459 |
|
|
2018
Q2 | $333K | Sell |
12,911
-8,485
| -40% | -$235K | ﹤0.01% | 2639 |
|
|
2018
Q1 | $511K | Buy |
+21,396
| New | +$675K | 0.01% | 2049 |
|
|
2017
Q4 | – | Sell |
-37,518
| Closed | -$1.05M | – | 5400 |
|
|
2017
Q3 | $794K | Buy |
+37,518
| New | +$688K | 0.01% | 1727 |
|
|
2016
Q1 | – | Sell |
-2,330
| Closed | -$66K | – | 5128 |
|
|
2015
Q4 | $66K | Buy |
+2,330
| New | +$39.2K | ﹤0.01% | 3260 |
|
Group One Trading's ADMS Position: Q4 2021 in Review
Group One Trading sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 16,483 shares — an estimated $81K sold.
Group One Trading first reported a position in ADMS in Q4 2015 and held it in 13 quarters. The position peaked at $794K in Q3 2017. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.
- Group One Trading reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- Group One Trading sold 16,483 Adamas Pharmaceuticals shares in Q4 2021, an estimated $81K.
- Group One Trading first reported a position in Adamas Pharmaceuticals in Q4 2015 and held it in 13 quarters.
- Group One Trading's Adamas Pharmaceuticals position peaked at $794K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.
Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.